JPRN-UMIN000012613已完成未知
Reduction or withdrawal of etanercept after remission with etanerceptin patients with rheumatoid arthritis patients. - Reduction of etanercept after remission in RA patients.
Dept. of orthopedic surgery, Osaka Medical College0 个研究点目标入组 30 人开始时间: 2013年12月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients withoout remission stage(DAS28 under 2.6) after etanercept50mg/wk or25mg twice/wk
研究者
相似试验
进行中（未招募）
1 期
Dose Reduction or Discontinuation of Etanercept in Methotrexate-Treated Rheumatoid Arthritis Subjects Who Have Achieved a Stable Low Disease Activity-state (DOSERA) - DOSERARheumatoid Arthritis (RA) patients who are on Etanercept (ETN) treatment and are in remission or in a Low Disease Activity (LDA) stateMedDRA version: 9.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisEUCTR2007-006657-63-HUWyeth Pharmaceuticals France186
进行中（未招募）
不适用
Study comparing the effect on disease activity when reducing or discontinuing Etanercept in subjects with Rheumatoid Arthritis (RA) (DOSERA)EUCTR2007-006657-63-DKPfizer Ltd., Ramsgate Road,Sandwich,Kent,CT13 9NJ,United Kingdom72
进行中（未招募）
不适用
Study comparing the effect on disease activity when reducing or discontinuing Etanercept in subjects with Rheumatoid Arthritis (RA) (DOSERA)EUCTR2007-006657-63-ISPfizer Ltd., Ramsgate Road,Sandwich,Kent,CT13 9NJ,United Kingdom72
进行中（未招募）
不适用
Study comparing the effect on disease activity when reducing or discontinuing Etanercept in subjects with Rheumatoid Arthritis (RA) (DOSERA)Rheumatoid Arthritis (RA) patients who are on Etanercept (ETN) treatment and are in remission or in a Low Disease Activity (LDA) stateMedDRA version: 14.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2007-006657-63-FIPfizer Ltd., Ramsgate Road,Sandwich,Kent,CT13 9NJ,United Kingdom72
进行中（未招募）
不适用
Study comparing the effect on disease activity when reducing or discontinuing Etanercept in subjects with Rheumatoid Arthritis (RA) (DOSERA)Rheumatoid Arthritis (RA) patients who are on Etanercept (ETN) treatment and are in remission or in a Low Disease Activity (LDA) stateMedDRA version: 14.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2007-006657-63-SEPfizer Ltd., Ramsgate Road,Sandwich,Kent,CT13 9NJ,United Kingdom72